(Total Views: 596)
Posted On: 04/13/2021 12:26:53 PM
Post# of 145247
Re:
The decision to stop the study is not due to efficacy or safety concerns, Gilead said
Off the record he went on to say ... "We (FDA and Gilead) ignored those long ago."
The decision to stop the study is not due to efficacy or safety concerns, Gilead said
Off the record he went on to say ... "We (FDA and Gilead) ignored those long ago."
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)